Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Neuroblastoma 31Central Nervous System Neoplasms 25Astrocytoma 13Medulloblastoma 11Brain Neoplasms 10Testicular Neoplasms 9Sarcoma 8Testicular Germ Cell Tumor 7Teratoma 7Ovarian Neoplasms 7Oligodendroglioma 7Choroid Plexus Neoplasms 7Familial ependymoma 6Neuroectodermal Tumors, Primitive, Peripheral 5Gliosarcoma 5Glioblastoma 5Rhabdoid Tumor 4Retinoblastoma 4Glioma 4Ependymoma 4Wilms Tumor 3Ovarian Germ Cell Cancer 3Optic Nerve Glioma 3Lymphoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Ovarian Epithelial 3Teratoma, Testicular 2Seminoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Filgrastim 2Docetaxel 2etoposide phosphate 1entinostat 1Thalidomide 1SUB1 protein, human 1Peripheral Blood Stem Cell Transplantation 1Ifosfamide 1Gemcitabine 1Etoposide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Peripheral Blood Stem Cell Transplantation × CNS × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡